Annual Drug Patent Expirations for UPNEEQ
Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are four patents protecting this drug.
This drug has twenty-six patent family members in twenty-two countries.
The generic ingredient in UPNEEQ is oxymetazoline hydrochloride. Additional details are available on the oxymetazoline hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Rvl Pharms drug UPNEEQ